TABLE 2.

Changes in mRNA expression from pretreatment to week 1 of therapy for all patients^a

Analyte	Mean fold change in expression factor at wk 1	SE	P
IL-4*b	2.77	0.5-17.95	0.038
IL-4	0.26	0.047-1.93	0.006
IL-4δ2	32.19	1.87-631.5	0.0001
TGF-β	1.09	0.1-11.93	0.7
TGF-βRII	1.3	0.087-21.42	0.54
Foxp3	2.6	0.29-27.05	0.093
GATA-3	1.94	0.24-16.58	0.188
T-bet	2.047	0.109-40.55	0.214
IFN-γ	2.48	0.304-17.49	0.065

^aThe expression factors represent the transcript expression level at week 1 compared to that at the pretreatment time point. Statistically significant P values are shown in bold.

^bThe primers used amplified both IL-4 and IL-4δ2.